Structure-activity studies on novel polymyxin derivatives that carry only three positive charges

Peptides

Volumn 31, Issue 12, 2010, Pages 2318-2321

  Vaara, Martti ^a,b   Vaara, Timo ^a  

^a Technopolis   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATION; FATTY ACID; NAB 7061; NAB 739; NAB 750; NAB 751; NAB 771; NAB 781; NAB 782; PEPTIDE; POLYMYXIN DERIVATIVE; RIFAMPICIN; SERINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; KIDNEY TUBULE EPITHELIUM; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; STRUCTURE ACTIVITY RELATION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; POLYMYXINS; PSEUDOMONAS AERUGINOSA; STRUCTURE-ACTIVITY RELATIONSHIP;

NEGIBACTERIA;

EID: 78049464981     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.09.010     Document Type: Article

References (20)

1. F.E. Ali, G. Cao, A. Poydal, T. Vaara, R.L. Nation, and M. Vaara Pharmacokinetics of novel antimicrobial cationic peptides NAB7061 and NAB739 in rats following intravenous administration J Antimicrob Chemother 64 2009 1067 1070
2. C.A. Arias, and B.E. Murray Antibiotic-resistant bugs in the 21st century - a clinical super-challenge New Engl J Med 360 2009 439 443
3. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards Jr., D. Gilbert, and L.B. Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
4. L.C. Henderson, J. Li, R.L. Nation, T. Velkov, and F.M. Pfeffer Developing an anion host for lipid A binding and antibacterial activity Chem Commun (Camb) 46 2010 3197 3199
5. 3 to antimicrobial and lipopolysaccharide binding activity Chem Pharm Bull 57 2009 240 244
6. N. Katsuma, Y. Sato, K. Ohki, K. Okimura, K. Ohnishi, and N. Sakura Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity Chem Pharm Bull 57 2009 332 336
7. D. Landman, C. Georgescu, D.A. Martin, and J. Quale Polymyxins revisited Clin Microbiol Rev 21 2008 449 465
8. D. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Suppl 1 2009 i29 i36
9. R.L. Nation, and J. Li Colistin in the 21st century Curr Opin Infect Dis 22 2009 535 543
10. G. Pirri, A. Giuliani, S.F. Nicoletto, L. Pizzuto, and A.C. Rinaldi Lipopeptides as anti-infectives: a practical perspective Cent Eur J Biol 4 2009 258 273
11. H. Tsubery, I. Ofek, S. Cohen, and M. Fridkin N-terminal modifications of polymyxin B nonapeptide and their effect on antibacterial activity Peptides 22 2001 1675 1681
12. H. Urakawa, K. Yamada, K. Komagoe, S. Ando, H. Oku, and T. Katsu Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides Bioorg Med Chem Lett 20 2010 1771 1775
13. M. Vaara Agents that increase the permeability of the outer membrane Microbiol Rev 56 1992 395 411
14. M. Vaara New approaches in peptide antibiotics Curr Opin Pharmacol 9 2009 571 576
15. M. Vaara, J. Fox, G. Loidl, O. Siikanen, J. Apajalahti, and F. Hansen Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents Antimicrob Agents Chemother 52 2008 3229 3236
16. M. Vaara, O. Siikanen, J. Apajalahti, J. Fox, N. Frimodt-Møller, and H. He A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane Antimicrob Agents Chemother 54 2010 3341 3346
17. M. Vaara, O. Siikanen, J. Apajalahti, N. Frimodt-Møller, and T. Vaara Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampin and clarithromycin J Antimicrob Chemother 65 2010 942 945
18. T. Velkov, P.E. Thompson, R.L. Nation, and J. Li Structure-activity relationships of polymyxin antibiotics J Med Chem 53 2010 1898 1916
19. P. Viljanen, and M. Vaara Susceptibility of Gram-negative bacteria to polymyxin B nonapeptide Antimicrob Agents Chemother 25 1984 701 705
20. C. Vingsbo Lundberg, T. Vaara, N. Frimodt-Møller, and M. Vaara Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice J Antimicrob Chemother 65 2010 981 985